par 209 par 209 (Propafenone Hydrochloride Extended Release 225 mg)
Pill with imprint par 209 par 209 is White, Capsule-shape and has been identified as Propafenone Hydrochloride Extended Release 225 mg. It is supplied by AvKARE, Inc..
Propafenone is used in the treatment of atrial fibrillation; ventricular tachycardia; wolff-parkinson-white syndrome; atrial flutter and belongs to the drug class group I antiarrhythmics. Risk cannot be ruled out during pregnancy. Propafenone 225 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for par 209 par 209
Propafenone Hydrochloride Extended Release
- Imprint
- par 209 par 209
- Strength
- 225 mg
- Color
- White
- Size
- 22.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Group i antiarrhythmics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- AvKARE, Inc.
- National Drug Code (NDC)
- 42291-0545
- Inactive Ingredients
-
ethylcelluloses,
lactose anhydrous,
magnesium stearate,
povidone,
titanium dioxide,
gelatin,
D&C Yellow No. 10,
ferrosoferric oxide,
butyl alcohol,
propylene glycol,
FD&C Blue No. 1,
FD&C Blue No. 2,
FD&C Red No. 40,
shellac
Note: Inactive ingredients may vary.
Related Images for "par 209 par 209"
More about propafenone
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 60 Reviews
- Drug class: group I antiarrhythmics
- FDA Alerts (1)
Consumer resources
- Patient Information
- Propafenone (Advanced Reading)
- Propafenone Tablets
- Propafenone Sustained-Release Capsules
- Other brands
- Rythmol, Rythmol SR
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.